{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:03:36Z","timestamp":1791389016540,"version":"4.3.3"},"reference-count":28,"publisher":"Impact Journals, LLC","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,3]]},"DOI":"10.18632\/oncotarget.8404","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T08:44:40Z","timestamp":1459154680000},"page":"25826-25835","source":"Crossref","is-referenced-by-count":23,"title":["The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent <i>FGFR3<\/i> mutation in Han Chinese patients"],"prefix":"10.18632","volume":"7","author":[{"given":"Xiaotian","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Central Research Laboratory and Urology, Shandong University Second Hospital, Jinan, China"},{"name":"Department of Medicine, Division of Haematology and Centre for Molecular Medicine (CMM), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden"},{"name":"Karolinska Institutet-Shandong University Collaborative Laboratory for Cancer Research, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, Shandong University Qilu Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Haematology and Centre for Molecular Medicine (CMM), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden"},{"name":"Karolinska Institutet-Shandong University Collaborative Laboratory for Cancer Research, Jinan, China"},{"name":"Department of Urology, Shandong University Qilu Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Shandong University Nursing School, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shandong University School of Medicine, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Central Research Laboratory and Urology, Shandong University Second Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Central Research Laboratory and Urology, Shandong University Second Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Central Research Laboratory and Urology, Shandong University Second Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Bj\u00f6rkholm","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Haematology and Centre for Molecular Medicine (CMM), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden"},{"name":"Karolinska Institutet-Shandong University Collaborative Laboratory for Cancer Research, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidong","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Urology, Shandong University Qilu Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengtian","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Central Research Laboratory and Urology, Shandong University Second Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Haematology and Centre for Molecular Medicine (CMM), Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden"},{"name":"Karolinska Institutet-Shandong University Collaborative Laboratory for Cancer Research, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,26]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/MOU.0b013e328356ad0e","article-title":"Biomarkers for bladder cancer aggressiveness","volume":"22","author":"Vlahou","year":"2012","journal-title":"Curr Opin Urol"},{"key":"2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","article-title":"European guidelines on upper tract urothelial carcinomas: 2013 update","volume":"63","author":"Shariat","year":"2013","journal-title":"Eur Urol"},{"key":"3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2008.06.013","article-title":"FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours","volume":"55","author":"Catto","year":"2009","journal-title":"Eur Urol"},{"key":"4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.urolonc.2010.07.014","article-title":"Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancer","volume":"31","author":"Siddiqi","year":"2013","journal-title":"Urol Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2013.08.052","article-title":"Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome","volume":"65","author":"Lorente","year":"2014","journal-title":"Eur Urol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/ijc.29526","article-title":"Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer","volume":"137","author":"Kumar","year":"2015","journal-title":"Int J Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1634\/theoncologist.2014-0391","article-title":"TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer","volume":"20","author":"Xu","year":"2015","journal-title":"Oncologist"},{"key":"8","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.18632\/oncotarget.1829","article-title":"TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas","volume":"5","author":"Xu","year":"2014","journal-title":"Oncotarget"},{"key":"9","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.1303607110","article-title":"TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal","volume":"110","author":"He","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10","doi-asserted-by":"publisher","first-page":"12428","DOI":"10.18632\/oncotarget.2660","article-title":"TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR","volume":"5","author":"Bjorkholm","year":"2014","journal-title":"Oncotarget"},{"key":"11","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.4161\/cc.24662","article-title":"Highly prevalent TERT promoter mutations in bladder cancer and brain gliobastoma","volume":"12","author":"Xing","year":"2013","journal-title":"Cell Cycle"},{"key":"12","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.1073\/pnas.1310522110","article-title":"TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism","volume":"110","author":"Kumar","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gde.2013.11.005","article-title":"TERT promoter mutations in cancer development","volume":"24","author":"Kumar","year":"2014","journal-title":"Curr Opin Genet Dev"},{"key":"14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00345-007-0213-4","article-title":"Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target","volume":"25","author":"Knowles","year":"2007","journal-title":"World J Urol"},{"key":"15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.aab0015","article-title":"The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer","volume":"348","author":"Chang","year":"2015","journal-title":"Science"},{"key":"16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.gene.2012.01.095","article-title":"Regulation of the human catalytic subunit of telomerase (hTERT)","volume":"498","author":"Tollefsbol","year":"2012","journal-title":"Gene"},{"key":"17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s11427-014-4666-6","article-title":"Telomerase as a \u201cstemness\u201d enzyme","volume":"57","author":"Xu","year":"2014","journal-title":"Sci China Life Sci"},{"key":"18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/MMBR.66.3.407-425.2002","article-title":"Human telomerase and its regulation","volume":"66","author":"Shay","year":"2002","journal-title":"Microbiol Mol Biol Rev"},{"key":"19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.urolonc.2009.06.007","article-title":"Bladder cancer: novel molecular characteristics, diagnostic, and therapeutic implications","volume":"28","author":"Zwarthoff","year":"2010","journal-title":"Urol Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1158\/1078-0432.CCR-05-1130","article-title":"Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors","volume":"11","author":"Orntoft","year":"2005","journal-title":"Clin Cancer Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.eururo.2015.07.039","article-title":"Genomic Characterization of Upper Tract Urothelial Carcinoma","volume":"68","author":"Hanrahan","year":"2015","journal-title":"Eur Urol"},{"key":"22","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.juro.2012.11.005","article-title":"FGFR3 mutation analysis in voided urine samples to decrease cystoscopies and cost in nonmuscle invasive bladder cancer surveillance: a comparison of 3 strategies","volume":"189","author":"Steyerberg","year":"2013","journal-title":"J Urol"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv186","article-title":"Racial Differences in BRAF\/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients","volume":"107","author":"Sinicrope","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"24","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1038\/sj.onc.1208705","article-title":"FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma","volume":"24","author":"Knowles","year":"2005","journal-title":"Oncogene"},{"key":"25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ng.907","article-title":"Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder","volume":"43","author":"Sun","year":"2011","journal-title":"Nat Genet"},{"key":"26","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/ng.2798","article-title":"Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation","volume":"45","author":"Li","year":"2013","journal-title":"Nat Genet"},{"key":"27","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1038\/onc.2013.446","article-title":"The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas","volume":"33","author":"Xu","year":"2014","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1002\/cncr.28800","article-title":"TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA","volume":"120","author":"Xu","year":"2014","journal-title":"Cancer"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T20:12:56Z","timestamp":1589227976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,26]]},"references-count":28,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016,5,3]]}},"alternative-id":["8404","27029078"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8404","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,26]]}}}